To describe the adverse effects associated with human serum albumin (HSA) administration.
DATA SOURCES:
A MEDLINE search and bibliography scanning were used to identify pertinent review articles, clinical studies, and case reports.
STUDY SELECTION:
Emphasis was placed on reporting the results of human studies with the primary objective of investigating adverse effects attributable to HSA administration. Clinical trials that reported the occurrence of adverse effects possibly associated with HSA were also reviewed. Animal data were included where pertinent.
DATA EXTRACTION:
Although isolated case reports were reviewed, data were primarily extracted from human studies involving large series of patients or studies that were randomized and prospective in nature.
DATA SYNTHESIS:
Alterations in coagulation, renal, cardiovascular, and pulmonary functions were identified as potential adverse effects following the administration of HSA. Occurrences of hypersensitivity reactions, trace metal loading, and serum amino acid alterations associated with these infusions were also noted and are described here. Pulmonary and cardiovascular systems appear to be particularly prone to complications from excessive HSA administration. Adverse effects such as HSA-induced hypersensitivity reactions may be severe, but occur infrequently.
CONCLUSIONS:
Controlled studies involving large numbers of patients are not currently available for an accurate assessment of the incidence of adverse effects attributable to HSA administration. Many of the reported reactions appear to be extensions of albumin's pharmacologic activities and would be expected to worsen following large doses of HSA.
Get full access to this article
View all access options for this article.
References
1.
RingJMessmerK. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet1977; 1: 466–9.
2.
RingJStephanWBrendelW. Anaphylactoid reactions to infusions of plasma protein and human serum albumin. Clin Allergy1979; 9: 89–97.
3.
WellsJVKingMA. Adverse reactions to human plasma proteins. Anaesth Intensive Care1980; 8: 139–44.
4.
GrammerLCShaughnessyMAPatersonBFPattersonR. Characterization of an antigen in acute anaphylactic dialysis reactions: Ethylene oxide-altered human serum albumin. J Allergy Clin Immunol1985; 76: 670–5.
5.
GrammerLCPatersonBFRoxeDDaugirdasJTIngTSIvanovichPT. IgE against ethylene oxide-altered human serum albumin in patients with anaphylactic reactions to dialysis. J Allergy Clin Immunol1985; 76: 511–4.
6.
StaffordCTLobelSAFrugeBCMoffittJEHoffRGFadelHE. Anaphylaxis to human serum albumin. Ann Allergy1988; 61: 85–8.
7.
JorgensenKAStoffersenE. On the inhibitory effect of albumin on platelet aggregation. Thromb Res1980; 17: 13–8.
8.
JorgensenKAStoffersenE. Heparin like activity of albumin. Thromb Res1979; 16: 569–74.
9.
JohnsonSDLucasCEGerrickSJLedgerwoodAMHigginsRF. Altered coagulation after albumin supplements for treatment of oligemic shock. Arch Surg1979; 114: 379–83.
10.
CogbillTHMooreEEDunnELCohenRG. Coagulation changes after albumin resuscitation. Crit Care Med1981; 9: 22–6.
11.
LedgerwoodAMLucasCEMammenEF. Effect of albumin resuscitation for shock on coagulation protein content. Surg Forum1980; 31: 13–4.
12.
LucasCELedgerwoodAMHigginsRF. Impaired salt and water excretion after albumin resuscitation for hypovolemic shock. Surgery1979; 86: 544–9.
13.
LucasCELedgerwoodAMHigginsRF. Glomerulotubular sodium dynamics after supplemental albumin resuscitation. Am Surg1981; 47: 204–7.
14.
MoonMRLucasCELedgerwoodAMKosinskiJP. Free water clearance after supplemental albumin resuscitation for shock. Circ Shock1989; 28: 1–8.
15.
BoerWHKoomansHAMeesEJ. Renal haemodynamics and sodium handling after hyperoncotic albumin infusion in sodium-restricted normal man. Eur J Clin Invest1987; 17: 442–7.
16.
KoppelCBaudischHIbeK. Inadvertent metal loading of critically ill patients with acute renal failure by human albumin solution infusion therapy. Clin Toxicol1988; 26: 337–56.
17.
HopferSMFayWPSundermanFW. Serum nickel concentrations in hemodialysis patients with environmental exposure. Ann Clin Lab Sci1989; 19: 161–7.
18.
CharhonSAChavassieuxPMMeunierPJAccominottiM. Serum aluminium concentration and aluminium deposits in bone in patients receiving haemodialysis. Br Med J1985; 290: 1613–4.
19.
MaharajDFellGSBoyceBFNgJPBoulton-JonesJMCummingRLC. Aluminium bone disease in patients receiving plasma exchange with contaminated albumin. Br Med J1987; 295: 693–6.
20.
MoussonCCharhonSAAmmarMAccominottiMRifleG. Aluminium bone deposits in normal renal function patients after long-term treatment by plasma exchange. Int J Artif Organs1989; 12: 664–7.
21.
FaloonWWEckhardtRDMurphyTLCooperAMDavidsonCS. An evaluation of human serum albumin in the treatment of cirrhosis of the liver. J Clin Invest1949; 28: 583–94.
22.
WatsonCJGreenbergA. Certain effects of salt poor human albumin in cases of hepatic disease. Am J Med Sci1949; 217: 651–7.
23.
WilkinsonPSherlockS. The effect of repeated albumin infusions in patients with cirrhosis. Lancet1962; 2: 1125–9.
24.
DahnMSLucasCELedgerwoodAMHigginsRF. Negative inotropic effect of albumin resuscitation for shock. Surgery1979; 86: 235–40.
25.
KovalikSGLedgerwoodAMLucasCEHigginsRF. The cardiac effect of altered calcium homeostasis after albumin resuscitation. J Trauma1981; 21: 275–9.
26.
SchlagGKroeslPRediHVoglC. Inotropic effect of different albumin solutions on isolated papillary muscle. Crit Care Med1985; 13: 661–3.
LucasCELedgerwoodAMHigginsRFWeaverDW. Impaired pulmonary function after albumin resuscitation from shock. J Trauma1980; 20: 446–51.
29.
MoyerEDBorderJRCerraFBCaruanaJChenierRMcMenamyRH. Multiple systems organ failure: IV. Imbalances in plasma amino acids associated with exogenous albumin in the trauma-septic patient. J Trauma1981; 21: 543–7.
30.
RothchildMAOratzMSchreiberSS. Albumin synthesis. N Engl J Med1972; 286: 748–57.
31.
DoweikoJPNompleggiDJ. Role of albumin in human physiology and pathophysiology. JPEN J Parenter Enteral Nutr1991; 15: 207–11.
32.
ErstadBLGalesBJRappaportWD. The use of albumin in clinical practice. Arch Intern Med1991; 151: 901–11.
33.
LucasCEBouwmanDLLedgerwoodAMHigginsR. Differential serum protein changes following supplemental albumin resuscitation for hypovolemic shock. J Trauma1980; 20: 47–51.
34.
WojtysiakSLBrownRORobersonDPowersDAKudskKA. Effect of hypoalbuminemia and parenteral nutrition on free water excretion and electrolyte-free water resorption. Crit Care Med1992; 20: 164–9.
35.
RozichJDPaulRV. Acute renal failure precipitated by elevated colloid osmotic pressure. Am J Med1989; 87: 358–60.
36.
FellGSMaharajD. Trace metal contamination of albumin solutions used for plasma exchange. Lancet1986; 2: 467–8.
37.
LoeligerEADe WolffFAMillinerDSFeldmanFShinabergerJHCoburnJW. Aluminum contamination of albumin-replacement solutions (letter). N Engl J Med1985; 312: 1389–90.
38.
QuagliaroDAGeraciVADwanREKentRSOlsonWP. Aluminum in albumin for injection. J Parenter Sci Technol1988; 42: 187–90.
39.
LeachCNSundermanFW. Nickel contamination of human serum albumin solutions (letter). N Engl J Med1985; 312: 1232.
GinesPTitoLArroyoVPlanasRPanesJViverJ. Randomized comparative study of therapeutic paracentesis with and without albumin in cirrhosis. Gastroenterology1988; 94: 1493–502.
42.
GinesPArroyoVVargusVPlanasRCasafontFPanesJ. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites. N Engl J Med1991; 325: 829–35.
43.
HeafJG. Albumin-induced changes in the electrocardiographic QRS complex. Am J Cardiol1985; 55: 1530–3.
44.
GoodwinCWLongJWMasonADPruittBA. Paradoxical effect of hyperoncotic albumin in acutely burned children. J Trauma1981; 21: 63–5.
45.
MoncriefJA. Burns II. Initial treatment. JAMA1979; 242: 179–82.
46.
BirkeGLiljedahlSOPlantinLO. Distribution and losses of plasma proteins during the early stages of severe burn. Ann N Y Acad Sci1968; 150: 895–904.
47.
MetildiLAShackfordSRVirgilioRWPetersRM. Crystalloid versus colloid in fluid resuscitation of patients with severe pulmonary insufficiency. Surg Gynecol Obstet1984; 158: 207–12.
48.
ByrickRJKayJCNobleWH. Extravascular lung water accumulation in patients following coronary artery surgery. Can Anaesth Soc J1977; 24: 332–45.
49.
LoweRJMossGSJilekJLevineHD. Crystalloid versus colloid in the etiology of pulmonary failure after trauma—a randomized trial in man. Crit Care Med1979; 7: 107–12.
50.
MessmerKFW. The use of plasma substitutes with special attention to their side effects. World J Surg1987; 11: 69–74.
